Instrument overview
GOSSGossamer Bio Inc
StockNasdaqUnited StatesHealth careEU retail investors: available
+3.7% today · −94.7% over a year
No score: too little data.
Quality, Trend, Stability: among the weakest. No dividend.
Gossamer Bio Inc (GOSS) belongs to the Health care sector and is listed on Nasdaq; country: United States. Over the past 12 months the price changed by −94.7%, with an annualised volatility of 200% and a largest fall of 97%. Hard red flags in our rules-based screen: Heavy dilution, Financial distress.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Profitability, balance-sheet safety, growth and capital discipline versus peers. More in the glossary →better than 0% of peers
Price trend over the last 12 and 6 months (excluding the last month) and distance from the 52-week high. More in the glossary →better than 1% of peers
Lower price swings, lower market sensitivity (beta) and shallower drawdowns score higher. More in the glossary →better than 1% of peers
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- 12-month trend (ex last month)weighs on the score · better than 0% of peers
- Volatility (1 y)weighs on the score · better than 0% of peers
- Share issuance (1 y)weighs on the score · better than 6% of peers
Red flags and notes
- Serious warning. Share count growing more than 10 % a year over three years. More in the glossary → Share count growing more than 10 % a year over three years.
- Serious warning. Altman Z in the distress zone and negative free cash flow. More in the glossary → Altman Z in the distress zone and negative free cash flow.
- Caution. Negative free cash flow in at least two of the last three years. More in the glossary → Negative free cash flow in at least two of the last three years.
- Caution. Accruals or the Beneish M-score are in the watch zone. More in the glossary → Accruals or the Beneish M-score are in the watch zone.
- Caution. Net debt above 4× EBITDA or interest cover below 2×. More in the glossary → Net debt above 4× EBITDA or interest cover below 2×.
- Caution. Book equity is below zero. More in the glossary → Book equity is below zero.
- Caution. At least one reverse split in the last three years. More in the glossary → At least one reverse split in the last three years.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Dividends
- Dividend yield
- 0.00%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- +3.7%
- 1 month
- −9.4%
- 1 year
- −94.7%
- Volatility, 1 yr
- 200.1%
- Max drawdown, 1 yr
- −97.2%
- Beta
- 1.34
Returns are price changes from end-of-day prices, without dividends.
Similar companies
Same sector, closest in price swings over the past year.
| REPLReplimune Group Inc. | 1/10 | 0.0% | 154.4% |
|---|---|---|---|
| KRSAKorsana Biosciences Inc. | —/10 | 0.0% | 162.5% |
| ADAPAdaptimmune Therapeutics | —/10 | 0.0% | −50.0% |
| AGLagilon health inc. | 1/10 | 0.0% | 550.7% |
| ATRAAtara Biotherapeutics Inc | —/10 | 0.0% | −33.4% |
| KODKodiak Sciences Inc | 1/10 | 0.0% | 487.6% |
| MRNAModerna Inc | 2/10 | 0.0% | 944.8% |
| ZNTLZentalis Pharmaceuticals | —/10 | 0.0% | 32.3% |
News and filings
- Gossamer Bio, Inc.: 8-K — Shareholder vote results
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 28 Oct 2026
- Gossamer Bio, Inc.: 8-K — Other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Sep 2026
- Gossamer Bio, Inc.: 8-K — Other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 24 Sep 2026
- Gossamer Bio, Inc.: 8-K — Director or officer change
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 17 Sep 2026
- Gossamer Bio, Inc.: 8-K — Change to security holders' rights; charter or bylaw amendment; other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 11 Sep 2026
- Gossamer Bio, Inc.: 8-K — Other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 9 Sep 2026
- Gossamer Bio, Inc.: 8-K — Charter or bylaw amendment
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 4 Sep 2026
- Gossamer Bio, Inc.: 8-K — Charter or bylaw amendment
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 27 Aug 2026
- Gossamer Bio, Inc.: 8-K — Material agreement; unregistered sale of equity; charter or bylaw amendment; Regulation FD disclosure
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 21 Aug 2026
- Gossamer Bio, Inc.: 8-K — Results of operations
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 14 Aug 2026
- Gossamer Bio, Inc.: 10-Q — Quarterly report for the period ending 30 Jun 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 14 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.